Chemokine Binding to Tenascin-C Influences Chemokine-Induced Immune Cell Migration
暂无分享,去创建一个
A. Kungl | K. Midwood | T. Gerlza | Martha Gschwandtner | M. Koch | Alissa Domaingo | Philipp Jokesch | Alexandra Schweiger | Kim S. Midwood | Tanja Gerlza
[1] M. Mörgelin,et al. Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2 , 2023, International journal of molecular sciences.
[2] C. Donovan,et al. Tenascin C in Lung Diseases , 2023, Biology.
[3] R. Tucker,et al. Advances on the roles of tenascin-C in cancer , 2022, Journal of cell science.
[4] A. Kungl,et al. The Role of Heparan Sulfate in CCL26-Induced Eosinophil Chemotaxis , 2022, International journal of molecular sciences.
[5] S. Bhattacharyya,et al. Tenascin-C in fibrosis in multiple organs: Translational implications. , 2022, Seminars in cell & developmental biology.
[6] K. Midwood,et al. Editorial: Tenascins – Key Players in Tissue Homeostasis and Defense , 2022, Frontiers in Immunology.
[7] O. Gualillo,et al. Chemokines and chemokine receptors in inflammatory bowel disease: recent findings and future perspectives. , 2021, Drug discovery today.
[8] R. Sachidanandam,et al. High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer , 2021, Nature Communications.
[9] A. Kungl,et al. Isolation and Characterization of Heparan Sulfate from Human Lung Tissues , 2021, Molecules.
[10] K. Imanaka-Yoshida. Tenascin-C in Heart Diseases—The Role of Inflammation , 2021, International journal of molecular sciences.
[11] N. Paul,et al. Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression , 2021, EMBO molecular medicine.
[12] A. Kungl,et al. Glycosaminoglycans located on neutrophils and monocytes impact on CXCL8- and CCL2-induced cell migration. , 2021, Cytokine.
[13] C. Deligne,et al. Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies? , 2021, Frontiers in Oncology.
[14] C. Weber,et al. Inflammatory Chemokines in Atherosclerosis , 2021, Cells.
[15] A. Sudo,et al. Tenascin-C in Osteoarthritis and Rheumatoid Arthritis , 2020, Frontiers in Immunology.
[16] Katarzyna Rolle,et al. Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment , 2020, PloS one.
[17] M. Congreve,et al. Impact of GPCR Structures on Drug Discovery , 2020, Cell.
[18] K. Midwood,et al. More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis , 2019, Front. Immunol..
[19] E. Krieger,et al. PEGylation of a glycosaminoglycan-binding, dominant-negative CXCL8 mutant retains bioactivity in vitro and in vivo. , 2019, Cytokine.
[20] Jihua Liu,et al. The effect of heparan sulfate on promoting amyloid fibril formation by β-casein and their binding research with multi-spectroscopic approaches. , 2019, Journal of photochemistry and photobiology. B, Biology.
[21] H. Kettenmann,et al. Tenascin C regulates multiple microglial functions involving TLR4 signaling and HDAC1 , 2019, Brain, Behavior, and Immunity.
[22] M. Najafi,et al. Extracellular matrix (ECM) stiffness and degradation as cancer drivers , 2018, Journal of cellular biochemistry.
[23] Olivier Stettler,et al. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration , 2018, FEBS letters.
[24] W. Gong,et al. Chemokines in homeostasis and diseases , 2018, Cellular & Molecular Immunology.
[25] M. Chiquet,et al. Tenascin-C at a glance , 2016, Journal of Cell Science.
[26] A. Kungl,et al. Exploring the glycosaminoglycan–protein interaction network by glycan‐mediated pull‐down proteomics , 2016, Electrophoresis.
[27] T. Oskarsson,et al. The extracellular matrix in breast cancer. , 2016, Advanced drug delivery reviews.
[28] A. Theocharis,et al. Extracellular matrix structure. , 2016, Advanced drug delivery reviews.
[29] Aid Atlić,et al. Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity. , 2015, Protein engineering, design & selection : PEDS.
[30] T. Oskarsson,et al. Tenascin C in metastasis: A view from the invasive front , 2015, Cell adhesion & migration.
[31] M. Chiquet,et al. Transcriptional regulation of tenascin genes , 2015, Cell adhesion & migration.
[32] Toshimichi Yoshida,et al. Tenascin-C and integrins in cancer , 2015, Cell adhesion & migration.
[33] K. Midwood,et al. Tenascin-C: Form versus function , 2014, Cell adhesion & migration.
[34] M. Chiquet,et al. Tenascins in stem cell niches. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[35] A. Kungl,et al. A Combinatorial Approach to Biophysically Characterise Chemokine-Glycan Binding Affinities for Drug Development , 2014, Molecules.
[36] S. Carr,et al. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver , 2014, BMC Cancer.
[37] J. Esko,et al. Demystifying heparan sulfate-protein interactions. , 2014, Annual review of biochemistry.
[38] E. Karnaukhova,et al. Oversulfated Chondroitin Sulfate Binds to Chemokines and Inhibits Stromal Cell-Derived Factor-1 Mediated Signaling in Activated T Cells , 2014, PloS one.
[39] M. Teixeira,et al. Designing CXCL8-based decoy proteins with strong anti-inflammatory activity in vivo , 2013, Bioscience reports.
[40] T. Williams,et al. Editorial: Are all eotaxins created equal? , 2013, Journal of leukocyte biology.
[41] M. Trinker,et al. Structure‐based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans , 2012, British journal of pharmacology.
[42] A. Zlotnik,et al. The chemokine superfamily revisited. , 2012, Immunity.
[43] Steven A. Carr,et al. The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices , 2011, Molecular & Cellular Proteomics.
[44] J. Prestegard,et al. Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data. , 2011, Structure.
[45] B. Langlois,et al. Advances in tenascin-C biology , 2011, Cellular and Molecular Life Sciences.
[46] Jinghang Zhang,et al. CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.
[47] Valerie M. Weaver,et al. The extracellular matrix at a glance , 2010, Journal of Cell Science.
[48] M. Bianchi,et al. Requirement of HMGB1 for stromal cell–derived factor–1/CXCL12–dependent migration of macrophages and dendritic cells , 2009, Journal of leukocyte biology.
[49] Risto Penttinen,et al. Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy , 2009, Pharmacological Reviews.
[50] G. Schultz,et al. Interactions between extracellular matrix and growth factors in wound healing , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[51] Ying-Yu Chen,et al. Monocyte Migration and LFA-1-Mediated Attachment to Brain Microvascular Endothelia Is Regulated by SDF-1α through Lyn Kinase1 , 2008, The Journal of Immunology.
[52] T. Curtis,et al. Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy. , 2008, Investigative ophthalmology & visual science.
[53] M. Ratajczak,et al. Migration of Bone Marrow and Cord Blood Mesenchymal Stem Cells In Vitro Is Regulated by Stromal‐Derived Factor‐1‐CXCR4 and Hepatocyte Growth Factor‐c‐met Axes and Involves Matrix Metalloproteinases , 2006, Stem cells.
[54] M. Jinnin,et al. Platelet derived growth factor induced tenascin‐C transcription is phosphoinositide 3‐kinase/Akt‐dependent and mediated by Ets family transcription factors , 2006, Journal of cellular physiology.
[55] N. C. Price,et al. How to study proteins by circular dichroism. , 2005, Biochimica et biophysica acta.
[56] T. Handel,et al. Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. , 2005, Annual review of biochemistry.
[57] S. Groshen,et al. Increased CXCL8 (IL-8) expression in Multiple Sclerosis , 2004, Journal of Neuroimmunology.
[58] S. Weis,et al. Expression of tenascin‐C in various human brain tumors and its relevance for survival in patients with astrocytoma , 2003, Cancer.
[59] Matthias Chiquet,et al. Tenascins: regulation and putative functions during pathological stress , 2003, The Journal of pathology.
[60] Timothy N. C. Wells,et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[61] T. Betsuyaku,et al. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema , 2002, Thorax.
[62] Shuhei Yamada,et al. Oversulfated Chondroitin/Dermatan Sulfates Containing GlcAβ1/IdoAα1–3GalNAc(4,6-O-disulfate) Interact with L- and P-selectin and Chemokines* , 2002, The Journal of Biological Chemistry.
[63] S. Rafii,et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. , 2001, Blood.
[64] P. Jones,et al. Tenascin-C in development and disease: gene regulation and cell function. , 2000, Matrix biology : journal of the International Society for Matrix Biology.
[65] M. Chiquet,et al. Rapid and reciprocal regulation of tenascin-C and tenascin-Y expression by loading of skeletal muscle. , 2000, Journal of cell science.
[66] Jennifer R. Harrington,et al. The Role of MCP‐1 in Atherosclerosis , 2000, Stem cells.
[67] C. Caux,et al. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines , 1999, Journal of leukocyte biology.
[68] D. Spillmann,et al. Defining the Interleukin-8-binding Domain of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.
[69] H. Augustin,et al. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. , 1998, Biochemical and biophysical research communications.
[70] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[71] R. Terkeltaub,et al. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.
[72] M. Baggiolini,et al. Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes , 1997, The Journal of experimental medicine.
[73] H. Erickson,et al. Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C. , 1997, Journal of cell science.
[74] T. Springer,et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) , 1996, The Journal of experimental medicine.
[75] H. Kondo,et al. Expression of the chemokine superfamily in rheumatoid arthritis , 1994, Clinical and experimental immunology.
[76] J. Hsuan,et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.
[77] E. Mackie,et al. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. , 1992, The American journal of pathology.
[78] Y. Kawarada,et al. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[79] Carlos A V Barreto,et al. Prediction and targeting of GPCR oligomer interfaces. , 2020, Progress in molecular biology and translational science.
[80] I. Udalova,et al. Expression and immune function of tenascin-C. , 2011, Critical reviews in immunology.
[81] B. Kamenov,et al. Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity. , 2009, Bratislavske lekarske listy.
[82] J. Couchman,et al. Syndecans as receptors and organizers of the extracellular matrix , 2009, Cell and Tissue Research.
[83] Masashi Suzuki,et al. Glycosaminoglycan affinity of the complete fibroblast growth factor family. , 2009, Biochimica et biophysica acta.
[84] K. Midwood,et al. J. Cell Commun. Signal. (2009) 3:287–310 DOI 10.1007/s12079-009-0075-1 RESEARCH ARTICLE The role of tenascin-C in tissue injury and tumorigenesis , 2009 .
[85] P. Proost,et al. The role of chemokines in inflammation , 1996, International journal of clinical & laboratory research.
[86] W. C. Johnson,et al. Structural information on proteins from circular dichroism spectroscopy possibilities and limitations. , 1995, Pharmaceutical biotechnology.